Cost Effectiveness of Adjunctive Quetiapine Fumarate Extended-Release Tablets with Mood Stabilizers in the Maintenance Treatment of Bipolar I Disorder

Author： >  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.28, Iss.9, 2010-09, pp. : 751-764

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Quetiapine Extended Release: Adjunctive Treatment in Major Depressive Disorder

By Sanford Mark  

CNS Drugs, Vol. 25, Iss. 9, 2011-09 ,pp. : 803-813

Adis International

Access to resources Recommend Favorite

Extended-Release Carbamazepine Capsules: In Bipolar I Disorder

By Tracy Swainston Harrison   Keating Gillian M.  

CNS Drugs, Vol. 19, Iss. 8, 2005-01 ,pp. : 709-716

Adis International

Access to resources Recommend Favorite

Maintenance Treatment Study Designs in Bipolar Disorder: Do They Demonstrate that Atypical Neuroleptics (Antipsychotics) are Mood Stabilizers?

By Goodwin Frederick K.  

CNS Drugs, Vol. 25, Iss. 10, 2011-10 ,pp. : 819-827

Adis International

Access to resources Recommend Favorite

Combination of aripiprazole with mood stabilizers for the treatment of bipolar disorder: from acute mania to long-term maintenance

By de Bartolomeis Andrea   Perugi Giulio  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 14, 2012-10 ,pp. : 2027-2036

Informa Healthcare

Access to resources Recommend Favorite

Quetiapine extended release: a guide to its use as adjunctive treatment in major depressive disorder

By Keating Gillian M.   Sanford Mark  

Drugs & Therapy Perspectives, Vol. 28, Iss. 3, 2012-03 ,pp. : 7-11

Adis International

Access to resources Recommend Favorite